Key Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$153K Buy
293
+3
+1% +$1.54K 0.03% 336
2026
Q2
$144K Hold
290
– – 0.02% 360
2026
Q1
$129K Hold
290
– – 0.02% 362
2025
Q4
$131K Hold
290
– – 0.02% 352
2025
Q3
$117K Hold
290
– – 0.02% 367
2025
Q2
$129K Hold
290
– – 0.03% 342
2025
Q1
$141K Sell
290
-16
-5% -$7.46K 0.03% 311
2024
Q4
$123K Buy
306
+16
+6% +$7.42K 0.03% 320
2024
Q3
$135K Sell
290
-11
-4% -$5.28K 0.03% 298
2024
Q2
$141K Buy
301
+251
+502% +$109K 0.03% 276
2024
Q1
$20.9K Hold
50
– – 0.01% 602
2023
Q4
$20.3K Hold
50
– – 0.01% 586
2023
Q3
$17.4K Hold
50
– – 0.01% 595
2023
Q2
$17.6K Buy
50
+32
+178% +$10.8K 0.01% 602
2023
Q1
$5.67K Hold
18
– – ﹤0.01% 801
2022
Q4
$5.21K Hold
18
– – ﹤0.01% 785
2022
Q3
$5K Hold
18
– – ﹤0.01% 810
2022
Q2
$5K Hold
18
– – ﹤0.01% 817
2022
Q1
$5K Hold
18
– – ﹤0.01% 809
2021
Q4
$4K Buy
+18
New +$3.5K ﹤0.01% 761

Other funds holding VRTX

Key Financial's VRTX Position: Q3 2026 in Review

Key Financial increased its Vertex Pharmaceuticals (VRTX) stake by 1% in Q3 2026, buying an estimated $1.54K and bringing the position to 293 shares worth $153K. The position accounts for 0.03% of the portfolio, ranked #336.

Key Financial first reported a position in VRTX in Q4 2021 and has held it in 20 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Key Financial held 293 shares of Vertex Pharmaceuticals worth $153K as of Q3 2026.
  • Key Financial bought 3 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.54K.
  • Vertex Pharmaceuticals made up 0.03% of Key Financial's portfolio in Q3 2026, its #336 holding.
  • Key Financial first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
  • 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.